Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination

未接种过乙肝疫苗的个体体内已存在的记忆性CD4 T细胞可在接种乙肝疫苗后提供强大的免疫力。

阅读:3
作者:George Elias # ,Pieter Meysman # ,Esther Bartholomeus # ,Nicolas De Neuter ,Nina Keersmaekers ,Arvid Suls ,Hilde Jansens ,Aisha Souquette ,Hans De Reu ,Marie-Paule Emonds ,Evelien Smits ,Eva Lion ,Paul G Thomas ,Geert Mortier ,Pierre Van Damme ,Philippe Beutels ,Kris Laukens # ,Viggo Van Tendeloo # ,Benson Ogunjimi #

Abstract

Antigen recognition through the T cell receptor (TCR) αβ heterodimer is one of the primary determinants of the adaptive immune response. Vaccines activate naïve T cells with high specificity to expand and differentiate into memory T cells. However, antigen-specific memory CD4 T cells exist in unexposed antigen-naïve hosts. In this study, we use high-throughput sequencing of memory CD4 TCRβ repertoire and machine learning to show that individuals with preexisting vaccine-reactive memory CD4 T cell clonotypes elicited earlier and higher antibody titers and mounted a more robust CD4 T cell response to hepatitis B vaccine. In addition, integration of TCRβ sequence patterns into a hepatitis B epitope-specific annotation model can predict which individuals will have an early and more vigorous vaccine-elicited immunity. Thus, the presence of preexisting memory T cell clonotypes has a significant impact on immunity and can be used to predict immune responses to vaccination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。